echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Lupus: Tytazeptide significantly increases SRI-4 response rates and reduces glucocorticoid doses in children with SLE in refractory children

    Lupus: Tytazeptide significantly increases SRI-4 response rates and reduces glucocorticoid doses in children with SLE in refractory children

    • Last Update: 2022-09-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Clinical data from a self-controlled trial of the safety and efficacy of a treatment of refractory children with systemic lupus erythematosus (cSLE) in a titazep, published in the journal Lupus
    .


    Results showed that 15 patients with refractory cSLE had a 66.


    The combination of tetazeptide and standard therapy can significantly improve the SRI-4 response rate in children with SLE, reduce the dose of glucocorticoids in patients with refractory cSLE, and have efficacy
    in lupus nephritis.


    In 15 children with refractory lupus erythematosus, disease activity improved or controlled in a relatively short period of time after the use of tetazep, and the dose of the hormone could be rapidly reduced or increased
    again.


    Because of its convenient use, few short-term side effects, and certain efficacy, tytazeptide shows certain advantages in children with refractory SLE, and its long-term side effects and efficacy are continuously observed
    .


    About Taytsip

    Tytasip is the antibody fusion protein drug molecule invented and designed by Professor Jianmin, CEO of Rongchang Bio and Chief Scientific Official
    .


    Internationally, a U.


    Original Source:

    Sun L, Shen Q, Gong Y, Li Y, Lv Q, Liu H, Zhao F, Yu H, Qiu L, Li X, He X, Chen Y, Xu Z, Xu H.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.